期刊文献+

Her-2/neu、p53和P-gp在非小细胞肺癌中的表达 被引量:2

Expressions of Her-2/neu,p53 and P-gp in Non-small Cell Lung Cancer
在线阅读 下载PDF
导出
摘要 [目的]探讨非小细胞肺癌(NSCLC)中Her-2/neu、p53和P-gp的表达及临床意义。[方法]采用免疫组化EnVision法,对60例NSCLC及其20例正常肺组织中Her-2/neu、p53和P-gp进行检测。[结果]Her-2/neu、p53和P-gp相关蛋白在NSCLC中的表达分别是75%、70%和75%,而正常组织未见表达(P均<0.01)。Her-2/neu的表达与病理类型和组织学分级呈相关性(P=0.031和P=0.047);p53的表达与淋巴结转移、临床分期有关(P=0.024和P=0.003);P-gp的表达与病理类型有关(P=0.020);三者之间,Her-2/neu的阳性表达与p53和P-gp的阳性表达存在明显正相关性(P=0.025和P=0.000),而p53的阳性表达与P-gp的阳性表达之间未见明显相关性(P=0.517)。[结论]Her-2/neu、p53和P-gp在NSCLC的发展过程中起了重要作用,联合检测该三项基因的表达将有助于判断是否存在肿瘤的原发耐药及治疗方案的选择。
出处 《肿瘤学杂志》 CAS 2007年第4期287-289,共3页 Journal of Chinese Oncology
  • 相关文献

参考文献10

  • 1Nakamura H,Kawasaki N,Taguchi M,et al.Association of HER-2 overexpression with prognosis in non-small cell lung carcinoma:a meta analysis[J].Cancer,2005,103(9):1865-1873.
  • 2Vallbohmer D,Brabender J,Yang DY,et al.Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer[J].Clin Lung Cancer,2006,7(5):332-337.
  • 3Tan D,Deeb G,Wang J,et al.HER-2/neu protein expression and gene alteration in stage Ⅰ~Ⅲ A non-small-cell lung cancer:a study of 140 cases using a combination of high throughput tissue microarray,immunohistochemistry,and fluorescent in situ hybridization[J].Diagn Mol Pathol,2003,12(4):201-211.
  • 4Paul A,Bunn JR,Helfrich B,et al.Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents[J].Clin Cancer Res,2001,7(10):3239-3250.
  • 5Herbst R,Glaccone G,Schiller JH,et al.Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer:a phase Ⅲ trial-INTACT2[J].J Clin Oncol,2004,22(5):785-794.
  • 6Bergqvist M,Brattstrom D,Larsson A,et al.The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival[J].BMC Cancer,2004,4(1):66.
  • 7Vogelstein B,Kinzler KW.p53 function and dysfunction[J].Cell,1992,70(4):523.
  • 8Fijolek J,Wiatr E,Rowinska-Zakrzewska E,et al.p53 and HER2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer[J].Int J Biol Markers,2006,21(2):81-87.
  • 9'Amato TA,Landreneau RJ,Ricketts W,et al.Chemotherapy resistance and oncogene expression in non-small cell lung cancer[J].J Thorac Cardiovasc Surg,2007,133(2):352-363.
  • 10Langer CJ,Stephenson P,Thor A,et al.Trastuzumab in the treatment of advanced non-small-cell lung cancer:is there a role? Focus on Eastern Cooperative Oncology Group study 2598[J].J Clin Oncol,2004,22(7):1180-1187.

同被引文献14

  • 1章雪林,薛松,郑家豪,刘沙.非小细胞肺癌中骨桥蛋白和P21的相关性研究[J].中国肺癌杂志,2007,10(4):288-290. 被引量:4
  • 2Xin-yun Wang,Zhi Yao,Yan Li,Ting Liu,Hai-yan Zheng,Cong-zhong Zhu,Cui-yun Sun,Ai-xiang Wang,Min Zhao,Xing-ye Wu.EXPRESSION AND SIGNIFICANCE OF SURVIVIN mRNA IN LUNG CANCER TISSUE MICROARRAY DETECTED BY FISH[J].Chinese Medical Sciences Journal,2005,20(3):214-216. 被引量:7
  • 3李作生,李保庆.p21和p27基因多态性与肿瘤的相关性[J].国际遗传学杂志,2006,29(4):317-320. 被引量:23
  • 4Ornella Cazzalini,Paola Perucca,Federica Valsecchi,Lucia A. Stivala,Livia Bianchi,Vanio Vannini,Ennio Prosperi.Intracellular localization of the cyclin-dependent kinase inhibitor p21CDKN1A-GFP fusion protein during cell cycle arrest[J]. Histochemistry and Cell Biology . 2004 (5)
  • 5A. A. Morgunkova,V. P. Almazov,S. M. Strunina,B. P. Kopnin,P. M. Chumakov.Dominant-Negative Inactivation of p53: The Effect of the Proportion between a Trans-Dominant Inhibitor and Its Target[J]. Molecular Biology . 2003 (1)
  • 6Pimlak Charoenkwan,Christof Senger,Sheila Weitzman,Elizabeth Sexsmith,Christopher G. Sherman,David Malkin,Paul S. Thorner.Significance of p53 Expression in Immature Teratomas[J]. Pediatric and Developmental Pathology . 2002 (5)
  • 7Prenzel N,Fischer O M,Streit S,et al.The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocrine Related Cancer . 2001
  • 8Schneider P M,Praeuer H W,Stoeltzing O,et al.Multiple molecular marker testing (p53,C-Ki-ras,c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer. British Journal of Cancer . 2000
  • 9Meert A P,Martin B,Paesmans M,et al.The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature. British Journal of Cancer . 2003
  • 10李向荣,林星余,肖忠秀,蒋海霞,唐琼兰,刘馨.p21结构功能与研究新进展[J].医学综述,2008,14(14):2094-2097. 被引量:25

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部